Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India.
Nat Commun. 2021 Apr 13;12(1):2199. doi: 10.1038/s41467-021-22385-9.
Norepinephrine is a biogenic amine neurotransmitter that has widespread effects on alertness, arousal and pain sensation. Consequently, blockers of norepinephrine uptake have served as vital tools to treat depression and chronic pain. Here, we employ the Drosophila melanogaster dopamine transporter as a surrogate for the norepinephrine transporter and determine X-ray structures of the transporter in its substrate-free and norepinephrine-bound forms. We also report structures of the transporter in complex with inhibitors of chronic pain including duloxetine, milnacipran and a synthetic opioid, tramadol. When compared to dopamine, we observe that norepinephrine binds in a different pose, in the vicinity of subsite C within the primary binding site. Our experiments reveal that this region is the binding site for chronic pain inhibitors and a determinant for norepinephrine-specific reuptake inhibition, thereby providing a paradigm for the design of specific inhibitors for catecholamine neurotransmitter transporters.
去甲肾上腺素是一种生物胺神经递质,对警觉性、觉醒和疼痛感知有广泛的影响。因此,去甲肾上腺素摄取的抑制剂已成为治疗抑郁症和慢性疼痛的重要工具。在这里,我们使用黑腹果蝇多巴胺转运蛋白作为去甲肾上腺素转运蛋白的替代物,并确定了转运蛋白在无底物和去甲肾上腺素结合形式下的 X 射线结构。我们还报告了转运蛋白与慢性疼痛抑制剂(包括度洛西汀、米那普仑和合成阿片类药物曲马多)复合物的结构。与多巴胺相比,我们观察到去甲肾上腺素以不同的构象结合,在主要结合位点内靠近亚位点 C 的位置。我们的实验表明,该区域是慢性疼痛抑制剂的结合位点,也是去甲肾上腺素特异性再摄取抑制的决定因素,从而为设计特定的儿茶酚胺神经递质转运蛋白抑制剂提供了范例。